Загрузка...
Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches
Monoclonal antibody (mAb)-based therapies have experienced considerable growth in cancer management. When labeled with radionuclides, mAbs also represent promising probes for imaging or theranostic approaches. Initially, mAbs have been radiolabeled with single-photon emitters, such as (131)I, (99m)T...
Сохранить в:
| Опубликовано в: : | Front Med (Lausanne) |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6558173/ https://ncbi.nlm.nih.gov/pubmed/31214593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2019.00124 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|